Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
Yuan X, Yang M, Chen X, Zhang X, Sukhadia S, Musolino N, Bao H, Chen T, Xu C, Wang Q, Santoro S, Ricklin D, Hu J, Lin R, Yang W, Li Z, Qin W, Zhao A.
Yuan X, et al. Among authors: zhao a.
Cancer Immunol Immunother. 2017 Mar;66(3):367-378. doi: 10.1007/s00262-016-1937-z. Epub 2016 Dec 8.
Cancer Immunol Immunother. 2017.
PMID: 27933426
Free PMC article.